Schedule 13G ownership disclosure
ZOSANO PHARMA CORP
Security class unavailable · CUSIP: 98979H202
Event date: 2018-02-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 32,500
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-18-000298
- Form type
- SC 13G
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Feb 09, 2018
- Reporting period
- Feb 06, 2018
- Description
- Schedule 13G beneficial ownership